A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
DUBLIN, Ireland, Oct. 16, 2019 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2019. Quarter 3 Results...
Conference Call Scheduled for October 16, 2019 at 11:00 am EASTERNDUBLIN, Ireland, Oct. 15, 2019 -- October 15, 2019 - Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
DUBLIN, Ireland, Aug. 20, 2019 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2019. Quarter 2 Results...
Conference Call Scheduled for August 20, 2019 at 11:00 am EASTERNDUBLIN, Ireland, Aug. 15, 2019 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...
DUBLIN, Ireland, May 07, 2019 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2019. Quarter 1 Results...
Conference Call Scheduled for May 7, 2019 at 11:00 am EASTERNDUBLIN, Ireland, May 01, 2019 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial...
DUBLIN, Ireland, March 07, 2019 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2018 and fiscal year...
Conference Call Scheduled for March 7, 2019 at 11:00 am EASTERN DUBLIN, Ireland, March 04, 2019 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...
DUBLIN, Ireland, Nov. 29, 2018 -- Trinity Biotech plc (Nasdaq: TRIB), today announced that Ronan O'Caoimh, CEO of Trinity Biotech, has increased his shareholding in Trinity Biotech by the acquisition of 425,000 ADRs. As a result of this transaction, Mr. O'Caoimh's...
DUBLIN, Ireland, Oct. 23, 2018 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2018. Quarter 3 Results...